Immatics (IMTX) Tax Provisions (2022 - 2025)
Immatics recorded quarterly Tax Provisions of $4.8 million in Q4 2025, up 3123.92% quarter-over-quarter from $148470.0 in Q3 2025, and up 145.99% year-over-year from $1.9 million in Q4 2024.
Immatics' Tax Provisions history runs 3 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- In Q4 2025, Tax Provisions rose 145.99% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $7.1 million (up 153.74% YoY), while the FY2025 annual figure was $2.2 million, up 134.32% from the prior year.
- Tax Provisions came in at $4.8 million for Q4 2025 at Immatics, up from $148470.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $4.8 million in Q4 2025 to a low of -$16.4 million in Q4 2022.
- A 3-year average of -$2.2 million and a median of -$150764.3 in 2024 frame the typical range for Tax Provisions.
- On a YoY basis, Tax Provisions climbed as much as 851.57% in 2025 and fell as far as 85.8% in 2025.
- Immatics' Tax Provisions stood at -$16.4 million in 2022, then jumped by 36.38% to -$10.4 million in 2024, then soared by 145.99% to $4.8 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $4.8 million, $148470.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 4.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 148,470.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | -10.41 Mn |
| Sep 30, 2024 | -3.24 Mn |
| Jun 30, 2024 | -150,764.26 |
| Mar 31, 2024 | 562,735.40 |
| Dec 31, 2022 | -16.36 Mn |
| Sep 30, 2022 | -562,617.08 |
| Jun 30, 2022 | -1.22 Mn |